US Broker Ratings

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Unveiling a 26.65% Potential Upside for Investors

Amneal Pharmaceuticals, Inc. (AMRX), a prominent player in the healthcare sector, specifically within the drug manufacturers specializing in specialty and generic medications, is garnering attention from investors due to its..

LifeStance Health Group, Inc. (LFST) Stock Analysis: A 55% Potential Upside Amid Growing Demand for Mental Health Services

LifeStance Health Group, Inc. (NASDAQ: LFST) is carving a significant niche within the healthcare sector, specifically in the medical care facilities industry. The company, headquartered in Scottsdale, Arizona, specializes in..

BioCryst Pharmaceuticals, Inc. (BCRX) Investor Outlook: Exploring a Potential 127.81% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) stands at the intriguing intersection of innovation and potential within the healthcare sector. Specializing in the development of oral small-molecule and injectable protein therapeutics for..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a Promising 27% Upside Potential

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of biotechnology innovation, leveraging cutting-edge CRISPR/Cas9 gene-editing technology to develop groundbreaking treatments for a wide array of serious human diseases. As..

Apellis Pharmaceuticals (APLS) Stock Analysis: Biotechnology Innovator with 65% Upside Potential

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is attracting attention with its promising pipeline and significant potential upside. With a market capitalization of $2.86 billion,..

Zai Lab Limited (ZLAB) Stock Analysis: Unpacking an Impressive 68% Potential Upside

Zai Lab Limited (NASDAQ: ZLAB) presents a compelling investment opportunity in the biotechnology sector, with analysts forecasting a considerable 68.26% potential upside from its current stock price of $32.93. This..

Concentra Group Holdings Parent (CON) Stock Analysis: Unveiling a 35% Upside Potential

Concentra Group Holdings Parent (NASDAQ: CON), a formidable player in the healthcare sector, presents an intriguing opportunity for investors eyeing the medical care facilities industry. With its operations rooted in..

Crinetics Pharmaceuticals, Inc. (CRNX) Stock Analysis: Exploring an 82% Potential Upside in Biotech Innovations

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), a prominent player in the biotechnology sector, is making waves with its innovative approach to treating rare endocrine diseases. Based in San Diego, California, Crinetics..

Perrigo Company plc (PRGO) Stock Analysis: A 57.62% Upside in Focus Amidst Healthcare Market Dynamics

Perrigo Company plc (PRGO), a prominent player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry, presents an intriguing opportunity for investors eyeing substantial gains. With..

Sarepta Therapeutics, Inc. (SRPT): Investor Outlook with a 24.59% Potential Upside

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology sector, particularly in the niche field of genetic therapies for rare diseases. As of the latest financial update,..

TransMedics Group, Inc. (TMDX) Stock Analysis: A 23% Upside Potential in the Innovative Organ Transplant Sector

TransMedics Group, Inc. (NASDAQ: TMDX) presents a compelling opportunity for investors seeking exposure to the healthcare sector, specifically within the medical devices industry. With a market capitalization of $3.88 billion,..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: 26% Revenue Growth and Promising Upside

iRhythm Technologies, Inc. (NASDAQ: IRTC) stands out as a formidable player in the healthcare sector, specifically within the medical devices industry. The company’s focus on developing and commercializing cutting-edge ambulatory..

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Promising Biotech Play with 58.58% Potential Upside

Avidity Biosciences, Inc. (NASDAQ: RNA), a pioneering entity in the biotechnology industry, is garnering attention from investors with its innovative approach to RNA therapeutics. Specializing in antibody oligonucleotide conjugates (AOCs),..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Uncovering a 22% Upside Potential Amidst Robust Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS), a leading player in the biotechnology sector, has caught the attention of investors with its promising genetic medicines portfolio and impressive growth metrics. As a..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring an 18.64% Potential Upside in the Rare Disease Biotech Space

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) stands as a noteworthy contender in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.59 billion, this Boston-based company focuses..

Charles River Laboratories (CRL) Stock Analysis: Navigating Market Volatility with a 19.64% Potential Upside

Charles River Laboratories International, Inc. (NYSE: CRL) stands at the forefront of the Healthcare sector, specializing in the Diagnostics & Research industry. With a market capitalization of $7.31 billion, Charles..

Cytokinetics, Incorporated (CYTK): Biotech Stock with 48% Upside Potential and Robust Revenue Growth

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector with a market capitalization of $6.03 billion and a formidable presence in muscle biology drug development. This late-stage biopharmaceutical..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring an 82.77% Potential Upside in the Biotech Sector

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a clinical-stage biopharmaceutical company, stands at a pivotal moment in its journey, offering an intriguing opportunity for investors in the healthcare sector. With a market..

TG Therapeutics, Inc. (TGTX) Investor Outlook: Strong Revenue Growth and Promising Pipeline Signal Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling figure in the biotechnology sector, captivating investors with its impressive revenue growth and innovative pipeline. Headquartered in Morrisville, North Carolina, TG..

ADMA Biologics Inc (ADMA) Stock Analysis: A Promising 86.16% Upside in the Biotech Sector

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is quietly navigating the healthcare sector with a focused mission to develop, manufacture, and market plasma-derived biologics targeting..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds